EBITDA for 2024 slightly grew by 0.9%, reaching SAR 1,595 million compared to SAR 1,581 million in the previous year. Nahdi ...

Nahdi Medical Co. expanded its pharmacy network in 2024, reaching 1,156 locations in Saudi Arabia and 25 in the UAE, CEO ...

The board members approved interim cash dividends of SAR 300 million, representing 30% of the capital, for the second half ...

Nahdi profit dips 8% to SAR 820.7M in 2024; Q4 at SAR 157.9M 12 M 2024 Nahdi’s 9M net profit rises to SAR 662.9M; Q3 at SAR 182.2M 9 M 2024 Nahdi’s H1 2024 profit down 6% to SAR 480.7M; Q2 at SAR ...

Nahdi Medical Co. listed its shares on the Saudi Stock Exchange in March 2022 after raising $1.4 billion in an IPO, which was the largest listing on the Saudi bourse since Saudi Aramco’s $29.4 billion ...

First founded by Abdullah Al-Nahdi as a small pharmacy, the Al-Nahdi Family Office has since evolved to span logistics, transportation, education, catering, clean energy, and artificial intelligence.

Joharji assumed his current role in 2014. The Nahdi Medical Company has more than 1,180 retail pharmacies across Saudi Arabia and the U.A.E. covering 140 cities and villages, reaching 97% of the Saudi ...

Nahdi’s 9M net profit rises to SAR 662.9M; Q3 at SAR 182.2M 9 M 2024 Nahdi’s H1 2024 profit down 6% to SAR 480.7M; Q2 at SAR 247.7M 6 M 2024 Nahdi reports 5% net profit decline to SAR 232.9M in Q1 ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...